Home/Hedge Fund Intelligence/PTC Therapeutics, Inc.
Nasdaq: PTCTStockForm 13F30 Jun 2026

Hedge funds that hold PTC Therapeutics, Inc. Nasdaq: PTCT

CUSIP 69366J200 · who reports it, how much, and how much it matters to them

36 of the 720 hedge fund managers we track reported shares of PTC Therapeutics, Inc. (Nasdaq: PTCT) on Form 13F for 30 June 2026. Between them they reported USD 1.2bn. The largest position belongs to RTW Investments, at USD 632m. The manager with the most riding on it is Palo Alto Investors, where it is 10.4% of the reported book.

Managers reporting it36of 720 we track
Value they reportUSD 1.2bnshares only, 30 Jun 2026
Funds they run638with a file on PPLI.com
Largest positionUSD 632mRTW Investments
Typical weight0.0%median share of a manager's book
Heaviest weight10.4%Palo Alto Investors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

36 managers, USD 1.2bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports PTC Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1RTW Investments2 funds on PPLI.comUSD 632m5.4%
2D. E. Shaw & Co.15 funds on PPLI.comUSD 126m0.1%
3Armistice Capital1 fund on PPLI.comUSD 87m1.1%
4Palo Alto Investors6 funds on PPLI.comUSD 75m10.4%
5Citadel Advisors32 funds on PPLI.comUSD 61m0.0%
6Renaissance Technologies13 funds on PPLI.comUSD 59m0.1%
7Marshall Wace LLP84 funds on PPLI.comUSD 57m0.0%
8Boxer Capital Management1 fund on PPLI.comUSD 16m1.2%
9Rock Springs Capital Management2 funds on PPLI.comUSD 13m0.6%
10Hudson Bay Capital Management8 funds on PPLI.comUSD 13m0.0%
11Schonfeld Strategic Advisors30 funds on PPLI.comUSD 12m0.0%
12Aquatic Capital Management3 funds on PPLI.comUSD 6.8m0.2%
13Moore Capital Management7 funds on PPLI.comUSD 6.2m0.1%
14Capricorn Fund Managers8 funds on PPLI.comUSD 5.2m0.4%
15Exoduspoint Capital Management7 funds on PPLI.comUSD 4.7m0.0%
16Orbimed Advisors1 fund on PPLI.comUSD 4m0.1%
17Millennium Management6 funds on PPLI.comUSD 3.8m0.0%
18Engineers Gate Manager1 fund on PPLI.comUSD 2.2m0.0%
19Balyasny Asset Management25 funds on PPLI.comUSD 1.7m0.0%
20Walleye Capital8 funds on PPLI.comUSD 1.6m0.0%
21Verition Fund Management3 funds on PPLI.comUSD 1.2m0.0%
22Landscape Capital Management4 funds on PPLI.comUSD 1.2m0.1%
23Capital Fund Management S.A.12 funds on PPLI.comUSD 1.1m0.0%
24Tudor Investment Corporation10 funds on PPLI.comUSD 1.1m0.0%
25Lighthouse Investment Partners190 funds on PPLI.comUSD 914,0000.0%
26Two Sigma Investments35 funds on PPLI.comUSD 869,0000.0%
27Cinctive Capital Management5 funds on PPLI.comUSD 614,0000.0%
28Voleon Capital Management13 funds on PPLI.comUSD 550,0000.0%
29Capstone Investment Advisors25 funds on PPLI.comUSD 480,0000.0%
30Freestone Grove Partners1 fund on PPLI.comUSD 382,0000.0%
31Entrypoint Capital1 fund on PPLI.comUSD 379,0000.1%
32CIBC Asset Management69 funds on PPLI.comUSD 209,0000.0%
33Fulcrum Asset Management LLP7 funds on PPLI.comUSD 104,0000.0%
34Bayforest Capital1 fund on PPLI.comUSD 48,9420.0%
35The Quarry1 fund on PPLI.comUSD 2,2840.0%
36Summit Global Investments1 fund on PPLI.comUSD 6150.0%
Next: where it matters most
Where it matters most

For Palo Alto Investors it is 10.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Palo Alto InvestorsUSD 75m10.4%
2RTW InvestmentsUSD 632m5.4%
3Boxer Capital ManagementUSD 16m1.2%
4Armistice CapitalUSD 87m1.1%
5Rock Springs Capital ManagementUSD 13m0.6%
6Capricorn Fund ManagersUSD 5.2m0.4%
7Aquatic Capital ManagementUSD 6.8m0.2%
8Entrypoint CapitalUSD 379,0000.1%
9Moore Capital ManagementUSD 6.2m0.1%
10Renaissance TechnologiesUSD 59m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds PTC Therapeutics, Inc.

What is the ticker symbol of PTC Therapeutics, Inc.?

PTC Therapeutics, Inc. trades under the symbol PTCT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 69366J200.

Which hedge funds own PTC Therapeutics, Inc. (Nasdaq: PTCT)?

36 of the 720 hedge fund managers PPLI.com tracks reported PTC Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 632m), D. E. Shaw & Co. (USD 126m), Armistice Capital (USD 87m), Palo Alto Investors (USD 75m) and Citadel Advisors (USD 61m).

How many hedge funds hold PTC Therapeutics, Inc.?

36 managers in our coverage reported it, and between them they run 638 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on PTC Therapeutics, Inc.?

Palo Alto Investors, where the position was 10.4% of the reported 13F book at 30 June 2026.

Does this show who is short PTC Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with PTC Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.